AIMM Therapeutics in Strategic Partnership With Cosmo Pharmaceuticals S.p.A. to Combine Cosmo's Extended Release Technology & AIMM's High Quality Antibodies to Successfully Combat Gastrointestinal Disease
12/19/2012 9:41:54 AM
More...
|
AIMM Therapeutics Appoints Former Head Novartis Research Institutes Jan de Vries CEO, and John Womelsdorf VP Business Development
11/8/2012 10:15:29 AM
More...
|
AIMM Therapeutics Closes Financing Round With Life Sciences Fund Amsterdam
6/5/2009 11:08:41 AM
More...
|